Client(s): WHO Senegal
Services: Capacity Building and Learning
Technical expertise: Capacity Building and Learning
The 2014 World Health Organization (WHO) African Regional Committee adopted a resolution to control viral hepatitis B infection by reducing chronic hepatitis B prevalence to less than 2% in children under the age of five in all Members States by 2020. A key strategy for reaching this goal is to prevent mother-to-child transmission of hepatitis B virus (HBV) through timely delivery of hepatitis B vaccine at birth followed by at least two doses of hepatitis B vaccine.
Senegal planned to introduce a dose of monovalent hepatitis B birth dose (HepB-BD) into its Expanded Programme on Immunization (EPI) in January 2016.
In this context, EPI organized a workshop from December 7 to 11, 2015 in Mbour with the participation of 20 national EPI and MNCH staff, and immunization and training experts (WHO, USAID and Intrahealth).
GaneshAID was contracted by WHO to instructionally design a training package to empower health workers (EPI-MNCH) in administering timely (24h) the HepB-BD to all newborns in Senegal. The training package includes a training guide, a slideshow desk, a case-study, a set of pre and post-test questions, and a simplified job-aid.
The cascade training based on the package will establish pool of trainers at 14 regional (14 regions) and district levels (76 districts) before the introduction of the HepB-BD in Senegal.
To get more information, please contact:
Technical Expert: Dorothy Leab, Senior Health System Strengthening Specialist, Email: email@example.com